Ganfeng Lithium Returns to Annual Net Profit
By Jason Chau
China's Ganfeng Lithium returned to profitability in 2025, supported by a recovery in sales volumes and prices.
The lithium producer said Tuesday it swung to a net profit of 1.61 billion yuan last year, equivalent to $232.9 million, from a 2.07 billion yuan net loss in 2024.
Revenue rose to 22.80 billion yuan in 2025 from 18.73 billion yuan in the previous year.
The Chinese lithium producer attributed the return to profitability to a recovery in sales prices and a jump in sales volumes for its lithium salts and battery products, driven by shifts in supply and demand.
Stronger operating revenue, increased gains from disposals of subsidiaries, stakes in associate companies and its financial assets also supported 2025 results, the company said.
Ganfeng's Hong Kong-listed shares were last trading 1.4% lower, while its Shenzhen-listed shares were last down 0.7%.
Looking ahead, Citi expects mixed first-quarter results, with weaker margins at its battery segment partly offset by higher lithium prices and cost-saving measures.
Ganfeng, China's largest lithium compounds producer and the world's biggest lithium metal supplier, is a key player in the country's new energy supply chain. It products are used in industries including electric vehicles and energy storage.
Write to Jason Chau at jason.chau@wsj.com
(END) Dow Jones Newswires
March 30, 2026 22:55 ET (02:55 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States